Evidence map›Paper›PMID 42827832›Full record

ArticleFrontiers in public health2026

From evidence to implementation: a policy and health systems roadmap for cervical cancer elimination in India.

Latha Balasubramani, Purnima Madhivanan, Meenu Anand, Mridu Gupta, Priya Ganesh Kumar, Abhishek Shankar, Shobha S Krishnan

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Latha BalasubramaniDepartment of Oncology, GKNM Hospital, Coimbatore, India.
Purnima MadhivananPublic Health Research Institute of India, Mysuru, Karnataka, India.
Meenu AnandGlobal Cancer Prevention and Screening, American Cancer Society, Atlanta, GA, United States.
Mridu GuptaCancer Awareness, Prevention and Early Detection (CAPED), Gurugram, Haryana, India.
Priya Ganesh KumarPreventive Oncology, Sainiwas Healthcare, Mumbai, India.
Abhishek ShankarDepartment of Radiation Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Shobha S KrishnanGlobal Initiative Against HPV and Cervical Cancer (GIAHC), Durham, NC, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cervical cancer is the first cancer that can be eliminated, yet it remains a leading cause of cancer-related mortality among women in low- and middle-income countries. India accounts for a substantial share of the global burden, making its trajectory central to global elimination efforts. Although effective tools-including HPV vaccination, HPV-based screening, and treatment of precancerous lesions-are well established, progress has been uneven. The central challenge is no longer scientific discovery but large-scale implementation, building on India's demonstrated capacity for nationwide public health delivery through polio eradication, HIV/AIDS control, and COVID-19 vaccination. Methods: We conducted a conference-informed policy and implementation synthesis drawing on expert presentations from the International Papillomavirus Society (IPVS) 2025 "The World Could End Cervical Cancer If it Tried: spotlight on India" session, complemented by peer-reviewed literature and policy documents. A rapid thematic synthesis approach was used to identify and organize implementation priorities across the prevention and care continuum. Findings: Five interrelated priorities emerged. First, demand generation must move beyond awareness to trust-driven uptake through credible messengers and clear service pathways. Second, strengthening provider capacity is essential to improve vaccine confidence and recommendation practices across the clinical workforce. Third, screening programmes must be redesigned around completion of the care cascade rather than participation alone, with integrated pathways for triage and treatment. Fourth, community engagement should be embedded within service delivery and navigation systems to translate trust into sustained participation and follow-through. Fifth, governance, financing, and digital infrastructure-including national registries and interoperable data systems-are critical to enable coordinated, accountable scale-up. Across all domains, trust functions as a central cross-cutting mechanism linking awareness to uptake and continuity of care. Interpretation: Cervical cancer elimination in India is achievable but requires a shift from fragmented initiatives to coordinated national implementation. Bridging the gap between evidence and delivery will depend on aligning communication, workforce capacity, service integration, community engagement, and system-level governance with urgency and accountability. India's success will not only determine national outcomes but will be pivotal to achieving global cervical cancer elimination within this generation.

Indexed as

Delivery of Health CareDisease EradicationHealth PolicyUterine Cervical NeoplasmsEarly Detection of CancerFemaleHumansIndiaPapillomavirus InfectionsPapillomavirus VaccinesPapillomavirus Vaccinescervical cancer eliminationhealth systemsHPV vaccinationimplementation scienceIndiapolicy synthesisscreening

Identifiers

PMID42827832
PMCPMC13630779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.